Fairscale Capital, LLC Ark Genomic Revolution ETF (De Transaction History
Fairscale Capital, LLC
- $114 Billion
- Q3 2024
A detailed history of Fairscale Capital, LLC transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Fairscale Capital, LLC holds 642 shares of ARKG stock, worth $14,907. This represents 0.01% of its overall portfolio holdings.
Number of Shares
642
Previous 642
-0.0%
Holding current value
$14,907
Previous $17.6 Million
6.6%
% of portfolio
0.01%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ARKG
# of Institutions
287Shares Held
24.5MCall Options Held
3.02MPut Options Held
2.65M-
Jpmorgan Chase & CO New York, NY2.96MShares$68.6 Million0.01% of portfolio
-
Bank Of America Corp Charlotte, NC2.9MShares$67.4 Million0.01% of portfolio
-
Main Management ETF Advisors, LLC San Francisco, CA2.43MShares$56.4 Million2.95% of portfolio
-
Goldman Sachs Group Inc New York, NY1.81MShares$42.1 Million0.01% of portfolio
-
Citigroup Inc1.68MShares$39 Million0.03% of portfolio